These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3859399)

  • 21. Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
    Salvatorelli E; Menna P; Minotti G
    Future Cardiol; 2015 Jul; 11(4):363-6. PubMed ID: 26239550
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiotoxicity of anthracyclines].
    Laurent S; Colbert N; Izrael V; Motte G
    Ann Med Interne (Paris); 1984; 135(6):464-72. PubMed ID: 6391323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac complications from cancer therapy.
    Blaes AH
    Minn Med; 2010 Oct; 93(10):40-4. PubMed ID: 21140761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin cardiotoxicity in the elderly: old drugs and new opportunities.
    Carver JR; Schuster SJ; Glick JH
    J Clin Oncol; 2008 Jul; 26(19):3122-4. PubMed ID: 18591552
    [No Abstract]   [Full Text] [Related]  

  • 25. Prechemotherapy cardiac assessment.
    Moore S
    Oncol Nurs Forum; 2009 Sep; 36(5):503-6. PubMed ID: 19726391
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of cardiac function tests after anthracycline therapy in childhood. Implications for screening.
    Jakacki RI; Larsen RL; Barber G; Heyman S; Fridman M; Silber JH
    Cancer; 1993 Nov; 72(9):2739-45. PubMed ID: 8402498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Doxorubicin-induced cardiotoxicity: are there effective alternatives for prevention?].
    Canales MA
    Med Clin (Barc); 2010 Jan; 134(2):70-1. PubMed ID: 19896152
    [No Abstract]   [Full Text] [Related]  

  • 28. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.
    Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE
    Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography.
    Gillings S; Johnson J; Fulmer A; Hauck M
    Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive methods for the assessment of cardiac function.
    Calif Med; 1973 Sep; 119(3):21-37. PubMed ID: 4270111
    [No Abstract]   [Full Text] [Related]  

  • 32. Anthracyclines and cardiotoxicity.
    Birtle AJ
    Clin Oncol (R Coll Radiol); 2000; 12(3):146-52. PubMed ID: 10942330
    [No Abstract]   [Full Text] [Related]  

  • 33. Curing the cure: utilizing exercise to limit cardiotoxicity.
    Emter CA; Bowles DK
    Med Sci Sports Exerc; 2008 May; 40(5):806-7. PubMed ID: 18408620
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology].
    Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M
    Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthracycline-induced cardiac toxicity more likely in underweight childhood cancer survivors.
    Andolina JR; Dilley K
    J Pediatr Hematol Oncol; 2010 Jul; 32(5):411-5. PubMed ID: 20495481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of adriamycin cardiotoxicity by echocardiography.
    Ewy GA; Jones SE; Groves BM; Gaines JA
    Ariz Med; 1978 Jun; 35(6):402-5. PubMed ID: 687134
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G
    Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anthracycline cardiotoxicity. Review of the literature and presentation of a study protocol].
    Rodrigues M; Ferreira R; Marques MS
    Rev Port Cardiol; 1989 Dec; 8(12):871-6. PubMed ID: 2698692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How could we solve the diagnostic dilemma of doxorubicin toxicity in high-risk patients?
    Davutoglu V; Soydinc S; Akdemir I
    J Natl Med Assoc; 2004 May; 96(5):689-90. PubMed ID: 15160987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.